N
Google TrendNOVIG (2000+) — Novig Sign Up Bonus: ROTOWIRE Gets $50 in Trade Credits
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:novig2000+boise state vs fresno state500+sounders500+pedro pascal200+medicare2000+blade200+kings vs golden knights1000+white sox vs cleveland guardians match player stats1000+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "European Commission appro" (30 stories)

Top Headline Story

CPI | AkzoNobel, Axalta Near EU Approval for $25 Billion Merger
Lead StoryPYMNTS.compolitics
2d ago

CPI | AkzoNobel, Axalta Near EU Approval for $25 Billion Merger

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxPdDVuRzBHUjdDNzIzNWtKQnlPalAwaTI2NDFOVm1nT2pqM0RCVVRucUxlUFJPMXo4MS1yR285VkZob01YTlpkaGFwaldRd1Z1ZjA4MW1UaFpRU1RlTDV5S2JuZ0ttcUVWLWlucWdBNlNPMFhDLWJqbzMxRzNGUXJFNmptb1lBVEdROHdDbjk5Y2hWV2s?oc=5" target="_blank">CPI | AkzoNobel, Axalta Near EU Approval for $25 Billion Merger</a>  <font color="#6f6f6f">PYMNTS.com</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
2000+19m ago

novig

Novig Sign Up Bonus: ROTOWIRE Gets $50 in Trade Credits

Filter stories
500+19m ago

boise state vs fresno state

Boise State gets big health boost, but injury concerns remain vs. Fresno State

Filter stories
500+19m ago

sounders

NEvsSEA Starting XI: Dejan Joveljić and Yeimar return to starting lineup, Sebastian Gomez gets the nod

Filter stories
200+19m ago

pedro pascal

Pedro Pascal in ‘Behemoth!’: The Oscar-Worthy Role That He (and Latinos) Have Been Waiting For

Filter stories

Search Results for "European Commission appro"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Vodafone, Societe Generale Get European Commission Approval for OXG Joint Control
Yahoo Financeworld

Vodafone, Societe Generale Get European Commission Approval for OXG Joint Control

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxNV1FyMGZ6RDhBeU9HVjVCMDRRTVRNcUlQSTkxazVTRmtnMFhuSWV2bjFUSlJicHY1TnkyaExtRm5sZS1qTmpTZHlSa3FxYkh6T2pKa0dVSlF0VFF4dldvQmJ4NEF5MmlRYnI3R09ybmp0RXFGMWI5QjJOSFhsb3UzQjFrX1V3alA3d0NPM2NuUU5MRDVOdnZCek9GdEdPVFlsRm1OOEZEdUY0QQ?oc=5" target="_blank">Vodafone, Societe Generale Get European Commission Approval for OXG Joint Control</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
EU Merger Guidelines review: new economic studies inform Commission's approach to dynamic effects
Freshfieldsgeneral

EU Merger Guidelines review: new economic studies inform Commission's approach to dynamic effects

<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxNR2FhWVJDTnhhV2paVXFBMXB6Qk5VX1doNkh6TVE1Z3RHUll6TmMzN2wxWldSMXM0TlpJMEptb1Z3cnBmMnVuWEZBVGpyY0RWODVrX21hcWtacjFzcmFyb29PMDlMa2J1Y1ByV3FXbWduYXVwaWh0SnFHWFdrb2gyZVpvZ0xUY0djcmZTeXJxbEp0aUZIVUxnelV2QWFuUFRHSGNuMEdtWGtRZ2VnUkhaMTEtSUs0aW5FNjlnYTE4SFVaX0Y0cUhvYXdTazRpbnk0WXF5Q0s3SHdPN2c4N1F1dTM1RGs?oc=5" target="_blank">EU Merger Guidelines review: new economic studies inform Commission's approach to dynamic effects</a>  <font color="#6f6f6f">Freshfields</font>

Read Full StoryMore like this
European Commission Softens its Presumption-Based Approach in its Final Guidelines on Exclusionary Abuses
Wolters Kluwerworld

European Commission Softens its Presumption-Based Approach in its Final Guidelines on Exclusionary Abuses

<a href="https://news.google.com/rss/articles/CBMi8gFBVV95cUxPNnRISGFxWEc1by1uLUxYVGZfN0RtVUhHMmI5N19VVWRDZVk4OEM3SV94VGw2SEZRcHFtQWFxTGhiM1c3OENWZ1BMZU5rdTdaLU1Bd0lkTVAwOFRwNkdMOGoxZjk4aFcxZVllSTZrTldQY3dXZzhjM0FwRTFTd20tTWdveEJ6aV9Gak5NYXlTcjNDaTVQbEhTZFR2VGxFbm1Edk1KeUhmUXRIVUhpek1HRW1ZRHFnREROVTRueHE2OWg3VHMtRGNDM2FOcjdpczZ0TjE4dnFndUdLSGNoVkR3a3pCSnR6TjBka2liaWhYcDlsUQ?oc=5" target="_blank">European Commission Softens its Presumption-Based Approach in its Final Guidelines on Exclusionary Abuses</a>  <font color="#6f6f6f">Wolters Kluwer</font>

Read Full StoryMore like this
Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
PR Newswireworld

Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

<a href="https://news.google.com/rss/articles/CBMizAJBVV95cUxQTGh5aElCczZGcmNTenJscTBsR2dLRUlrQkk1VkRPWUZDV2FmRW81V0Q0Y1VWMlpYcFVHcmFxN3Jxa1R6S04wSXdULWVrbmhjWjUwNDlVa1g1VVFQQVJUZ3RKcXpETTc2NHVGdjQ4VU1DVHJZSXl1X2RkUFUxd1ZDZGdsVUZMdGV6NGFILUF1ZEdsbE11aWJodlhyeHM0d18ySDV6N1JIZVlwUHZ1a3hfdEV1SnhQb3dMdDdyOUdwR2VaTDY5b25VeTdKbUI3QktrYWxvSm5VOWJhV2pKNmZFcWFXNC1xY2VtMEc5YkdvcjFtZ1AteEtJRFc4SlpRWjVuZFM0OE50UHZ4ZF9EeG9FOGZrQndrMXYzQm9OMUJJenYxT0pFanJJcGxpVy0tUWtnbGZFa1pxNG5uVms2ZGpaMWdpSDFpUXV2QzY1Wg?oc=5" target="_blank">Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
The EU-US trade deal: restoring stability and predictability
European Commissiongeneral

The EU-US trade deal: restoring stability and predictability

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1iZXNCZkNwZUhEa1Z6eW5yeVl1cWktUkRJa2tuMnBIVmtQa3lYNlFIN2RUZWNCU1h3dmZqSy1CYjEwSFdiWEE4V2Vpc0R3NjZ6T05qaEgwWXpCRzhldWZURkNjNWZhNDRuQ29xV1FB?oc=5" target="_blank">The EU-US trade deal: restoring stability and predictability</a>  <font color="#6f6f6f">European Commission</font>

Read Full StoryMore like this
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations
Business Wireworld

Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations

<a href="https://news.google.com/rss/articles/CBMimgJBVV95cUxNVU5oUlhuLTNWXzQwa3RwZ2VJY2JoVU9RemdqOUwzeGNmRkhaSUN6NFpIVGNfbTJwa2R5QWp1SjhaSW5jc3BJSHNwdWZxNW44UzBRdUpYTFJ2TkJPUndma09DNWU0cWd4Q21icnFKSUJhOEVrQkxTTEhfSVBOT3AzdVpBNkM5dU52R1lib3htcmQ0MWNyWl85dzQ5UFBzdk9LRktqdXpFSGk2cnZhN1JMSzhxVXlGYnc5dVJjaHEzcmtEUUhydExMdVJOeVBkNVROa1lsSmp1UlhjajhJT3pfOFR1ZXJqeF9VLWk5SzFFeFp5WUFoVzlhaVhVaWc5NTU0cy1oaTBoN1JPd2dhNjc4VFE2OVRhQkxhNmc?oc=5" target="_blank">Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
EU antitrust regulators clear Paramount-WBD merger as it faces challenge by U.S. states
CNBCworld

EU antitrust regulators clear Paramount-WBD merger as it faces challenge by U.S. states

<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxPLUdyakdzUFZFeDdEeFIyTDNjc1U2MzRkbG9TZ094cE81SWNYNEdCaDFaWjlwZU4wc0RDdUVUSEdRMlJoWWNLTV91VnY0YlNYd1o5TlRLOTAxakNZZVB5aVdfQWk3UEtpaWR0S0tRSXlueHJUQ0UxUmdYSWp1a3dpdDdVenEzUdIBiwFBVV95cUxPcjdjd3ZvRDVvNEdYRmpTc0trVXh3QVMwVVAzVmhuYlJUR0pidUxGTkhfalJHWEpZWllLbGwyeHQ0Y2xvWGpqZTFzLWZFVUgycXNBeUs5cHpVcnI1ck9YYWRKaUhvUURETDdwYWVKUXI4RVVSN2ttcGhfVEF6eDhqOUFXbmx0UFc4aDFn?oc=5" target="_blank">EU antitrust regulators clear Paramount-WBD merger as it faces challenge by U.S. states</a>  <font color="#6f6f6f">CNBC</font>

Read Full StoryMore like this
EU defends digital tax approach, says ready to act if Turmp takes measures
Reutersgeneral

EU defends digital tax approach, says ready to act if Turmp takes measures

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxOM1dlY2NZdnFYeFhpa2xXT0k0bmluOTk2VjBuVmhpeERwUWcwdzNhelI4SmVGSTFWSWg0dEFHS3ktNXd3LUVOWmp5M19wQnV3Rm9JYkstcEVsaFQ3cm1wNGpVSUd4ZlVBaUoyU0N1TVBXbm9oSzEtV0ZwM3FWQ0M3ajZGQUgxY2hBOGRrNGVZWGZzLUYzX0hwMFpHNFJsYU1zeDhCaU1xXzlrZUVQWTJVZ2t3?oc=5" target="_blank">EU defends digital tax approach, says ready to act if Turmp takes measures</a>  <font color="#6f6f6f">Reuters</font>

Read Full StoryMore like this
Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved
GlobeNewswireworld

Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved

<a href="https://news.google.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?oc=5" target="_blank">Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved</a>  <font color="#6f6f6f">GlobeNewswire</font>

Read Full StoryMore like this
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis
Yahoo Financeworld

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxNSk9wTkViSTRZWHUzeUsyZGFrbWV6R2F2aHFiLTN3NnpBTi1EVVoyVXIzeWxzWkVqV1lsVGlNNktZcHBlYS04LW82dUc1b3pzbGFRV3hrM3dlUW1qeXFvV1V5Mm9CMmlrQXludGxLa2gzcDB2em4ySXV2TUxHUFV0aDdfUGxiQm4wMWM2WGQ0OGdUZEQ5dmsyN204di1USEZ3UWFuc1RwdTdOZw?oc=5" target="_blank">AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
Strategic Approach to Mitigating Europe’s Critical Dependencies
Intereconomics | Review of European Economic Policyworld

Strategic Approach to Mitigating Europe’s Critical Dependencies

<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxPMldSVFdBdFNodC1wOHZXOVhPZk45Z293WFR3U1RubFhLMUIzSVYwSTBXVm1DTnEydXhSSHJpY3Q4NVpMM1BfWm9STURUUjVWa1BvaVZTbkY4UWR1Nl9hWmgzZmFvb1Z3b183azNWeENxc2YzVXhnTm4xNUhmSVFiMnhiektlOHVVa3VVaXpReW9SRUw0MWhfT2N1MUZrbDEyYmlfNjNsa0p1TlRPT1g5SmpOX3MwMnpiM09hU2w2SC1hN2Q0VDE5aU5Ed1IzNDg?oc=5" target="_blank">Strategic Approach to Mitigating Europe’s Critical Dependencies</a>  <font color="#6f6f6f">Intereconomics | Review of European Economic Policy</font>

Read Full StoryMore like this
Novartis receives European Commission approval for Itvisma for spinal muscular atrophy
PharmaTimesworld

Novartis receives European Commission approval for Itvisma for spinal muscular atrophy

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxPUHo2c1h4a1AxVGZwZUl2ZTQyYmFfcFduanpvVzBRV0V4YURoWkg5N0p0bS1WeVZidWw3bC1xUE10eWNBbFNqODdZdHZJRERRRzRraHZQaFgzOWdoMlY3UndaRTQyY1hJNjZSeXFqR0t2UzVLZmZxWWFWb2hHcHFiUVk4a29zcWgweTlKOU5EOFBUdmVjc1R4aU5TaUR0NV9oLTZENFdaS09DcDcyWEJQQkJUb3VFRFk?oc=5" target="_blank">Novartis receives European Commission approval for Itvisma for spinal muscular atrophy</a>  <font color="#6f6f6f">PharmaTimes</font>

Read Full StoryMore like this
Progress at the Expense of Accountability: Why the European Commission’s Approach to DMA Compromise Falls Short
Wolters Kluwerworld

Progress at the Expense of Accountability: Why the European Commission’s Approach to DMA Compromise Falls Short

<a href="https://news.google.com/rss/articles/CBMi9wFBVV95cUxQZVBFdzNnZHVHMHJXbkhzb3VUNFhFOFJBVTVkSHBid1o2aEhOeTQxRVZ4R2hmNHpneEM1aGh3UDc0R1VLT3YxVGdFVlZSM0tuY1NLeENXZ3RzYm50eXRObFd1V25XSHlKYU1HZ2htM2xfR0tncTA5bDc4SzFsMFJvT1Zlb3g0VHV5eVMzaDdOREJhT3dsYi1hOU1zRGM0N1FLQXhLWGp2Z1gydzR0T0V5TWhVbGlfX19CU1RLRUVmdldkZU9wdW9odWpsTG5lQ0huU3gtbHo4TkVDcDBPN0hOUzc0cnlkZ2dJaFlRVnFXaUdZd3dJbUJn?oc=5" target="_blank">Progress at the Expense of Accountability: Why the European Commission’s Approach to DMA Compromise Falls Short</a>  <font color="#6f6f6f">Wolters Kluwer</font>

Read Full StoryMore like this
Paramount offers remedies for Warner deal, making EU approval likely
Reutersworld

Paramount offers remedies for Warner deal, making EU approval likely

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxOcnZiZko3RU9mbHZrUTE5eGRrYzBVaFF4M3hoeTVQNExvalIzbV9LNUZ5TmhjUE5CRGVXRTRPZmlza1E5aVpSSUJ1bU9ZaFNDR3pzc2NzMUE2M0V4NVM2N1Q5dDVWN09qOFRXOEFUQzB6eGhZVWxvQ1duLUtrXzFCbmhJdWJ6cmEza29hOEFsS29zQ2JFVWFVdmJ6bWMyU01Uc0UzVDA5RUw?oc=5" target="_blank">Paramount offers remedies for Warner deal, making EU approval likely</a>  <font color="#6f6f6f">Reuters</font>

Read Full StoryMore like this
EU-US trade: Council gives final approval for the tariff commitments under Joint Statement
consilium.europa.euworld

EU-US trade: Council gives final approval for the tariff commitments under Joint Statement

<a href="https://news.google.com/rss/articles/CBMi7gFBVV95cUxOM0J6Yks3RWo4Z2Nwc3NxOV9wazJUMDBETmdVRjZlX2JRVzB1SDh3WGc2TFJJMHdUSmQ2aUE1Um5QZU1YSERWQkNhbGltWnhVSEc4cGMwbzI0SlprRmVYRHBmZXk5bXJORFEyeGROdGFjTUNCY3pScU9nX3owYkJaOVFyU180NklaYzA2VXFLVDRRTGxKdlcxYjJfTldJc0ctcjU2Q0dIYnVQaTN4bkJEb3FoWTRoU1RmYkhGQmNaWGtRakh4MDVkVWtJSVplT1hJRHQtcVBqamNtRzFrbTlJSE9FQzVWNlFzWGF4UGJn?oc=5" target="_blank">EU-US trade: Council gives final approval for the tariff commitments under Joint Statement</a>  <font color="#6f6f6f">consilium.europa.eu</font>

Read Full StoryMore like this
Bavarian Nordic Receives European Commission Approval of
GlobeNewswireworld

Bavarian Nordic Receives European Commission Approval of

<a href="https://news.google.com/rss/articles/CBMinAJBVV95cUxOWDFHSV9KeDBCZVhyZzRmZURJQlF6a0ZWdVFIUGtOQzJJNXJQVElrRTA4VnBSemxzY25UYjd6RFFKTHhPQ3R4UDBtQW83YURRNk84cGx5M2pMRUt1VDJkOG9SbkhJS1U1VTlnbW5WMVNlbXFMdEFGTXRuUzRUVy1KLW84T3p0ZWx6MlBSLXlNUnNubk83NFViQTRZdUNRT1UwOExrcnpqQXJENjBkelN1SXZLN0FHN2diTXdvbXloYjQ0eks2WFFfUWN5ejNHOEl2Y3d5YlRweG9iLU9XQWdFdW85YjNVVVJObGEwN3FSaDRNWDRmak9RLUxnTlEzUE51RUNGWWJCVmh0SHBVNnRCUWxWRXU4VUhyek5nSg?oc=5" target="_blank">Bavarian Nordic Receives European Commission Approval of</a>  <font color="#6f6f6f">GlobeNewswire</font>

Read Full StoryMore like this
Explainer: Tesla's road towards Full Self-Driving approval in Europe
Reuterstech

Explainer: Tesla's road towards Full Self-Driving approval in Europe

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxPT2FfRDVPcnlmeDlYWGphWlQ5NHBSSkx6NU0xdHNYa1p3a3FmLURFZjhmcHMyYWM3VFpLU0ZvTHNiQk9ncmdMT3YxUFVLWnhoQW1hSUJCdmNHOEZ1RGFSUGdOakVLSTBGTzNvVE04el9UNUFBOUd2OWRLTDMzSWJsMzdqeFJJRG4yNHVSLWJDbTM1bEpRUm03dnRJWkJQR0k?oc=5" target="_blank">Explainer: Tesla's road towards Full Self-Driving approval in Europe</a>  <font color="#6f6f6f">Reuters</font>

Read Full StoryMore like this
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo
Yahoo Financeworld

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOaFN4blNpM0Y5d3dTTEhLZWZpd2tncndhV053WFZLY1pEN184YmFlSF9ZblRhb1dDNlNBTUllVVRHQTVxYml4QkFkZEs3bWZ3TUp4U1B5YlN3VHFDNU1DT0k1WU9LYVF0ZjVNR0t4WGtIVTZHaHVQb0VtSFJQWTVFU2RPbmtTZEUzT2REZTBsNHNEcnpkX1pnWDBpUXpsYnVwWUdtNXNFdVJMdw?oc=5" target="_blank">AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
A novel data-driven approach to identify EU areas under housing stress
joint-research-centre.ec.europa.euworld

A novel data-driven approach to identify EU areas under housing stress

<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxQNERxdm8zcWJNNWxwMjRRT0JPOEg4bHg2bHk3aVlFMmFtblpmWWVhcms1dUthVkhucXc5a1dVLW9ldFVzaW91YWZlTmdhc2ZzZlRzdndxaFVjT1hyOVkyODFLRDRwMWR2M2FfMC1JMXFpMGtZZFdERDl2M0c0MW5EYURXdjl6YWlvTVo5aG15YzNlbUEyeWRPOE1UNHRoZmxlR2JQcDVPLWVZSWdNNm9SRWk3MGZraDRsWEVwM0REdktwTUFRWjF6cjFUTEVYNkpEY3Z5LUhxMVhjTkE?oc=5" target="_blank">A novel data-driven approach to identify EU areas under housing stress</a>  <font color="#6f6f6f">joint-research-centre.ec.europa.eu</font>

Read Full StoryMore like this
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
Yahoo Financeworld

Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQR2RLRzJhMjlKUUZETWtnRDBYWGF4czQ0M0p3X0h3ZmYwVEpZNUw3VlhHSGx6MHJzWVhwZ0ZmZ3hoelZqV1VfZjRmUFZqQXVMWUtUOG0xTk9zS25nUXZjbkxBQnhadUx3LWRwLXI1dVB6WjFxWXh5ZU5TcmFVWVB0RGxONFNpMjJRS0xRSm9jaVRpQXlNdGJJcE9DeXZDcmF6ZVYxYUVYNEp0d2s?oc=5" target="_blank">Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
Laboratoires Pierre Fabre receives European Commission Approval for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metast
PR Newswireworld

Laboratoires Pierre Fabre receives European Commission Approval for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metast

<a href="https://news.google.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?oc=5" target="_blank">Laboratoires Pierre Fabre receives European Commission Approval for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metast</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
EU-Mexico: Council gives final approval to modernised trade agreement
consilium.europa.euworld

EU-Mexico: Council gives final approval to modernised trade agreement

<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxPRnFaU1pGNkNrTXY2eEhYUk5pbkJoRmwzT3ZKZXQ2LWtibUx2X3poTjVHM2lqMF9ERWtxaWZWREozdXp2a0V0OTcySElCTUtPakN4MUhOX2NEbThXUm9TNUFhZlFGWFc4NkNLTm9GZlpKc3EzOUNiZEh4T1J2Nks1Q2xfS0N3eGtsSEhUUWMxWWRwanRONGJlNTdzc181RlhjTUZMTWFpMGhielNPaENBZEJ1SHNSVzNjMEpZSlM0U1dVSDhReG1rUHZMc1BBV01rNlE?oc=5" target="_blank">EU-Mexico: Council gives final approval to modernised trade agreement</a>  <font color="#6f6f6f">consilium.europa.eu</font>

Read Full StoryMore like this
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
Yahoo Financeworld

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOSm1vZEp6UG4wNFNERnR5eHc5b2htang1RzNTRThUdjFHSzl3UzdUbmdnM1JTcjk0TkZfSndOb1BOR2UtNnZENEdfTlNxZVR2QnNENkN1TlRGNTN0cjNmb2dxZ2dVLUxiNXBpVC1mNmJrdGFUQjBZRVdDNGdIZ3RaTmZOaExnRVUtd25iSVJ3TDRKd204MkJHQk4xNTdGWnpJOXZpMXpxQ1kydw?oc=5" target="_blank">AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
European Commission’s Approval of CinnaGen’s Teriparatide Signals New Phase of Global Growth
The National Law Reviewworld

European Commission’s Approval of CinnaGen’s Teriparatide Signals New Phase of Global Growth

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxOX2VpeGgzSGVzN0EzTWhCcFVvOHVhNW1wZFptUzhCZDE1NXF4THJhQlNDQlJnVkxJajJCdENOUVZlVUhXbjBELTY2WXBxT1JTN3hIcE90QmNvUE1CRGFXQXNUMDU1b1BHRzU4RlY5QXU4cjJ1WndzcmJNa0p6N3BXNC1zSkdaLTBxRHpFd0c1U3psSWU1NzRTd2VLcTJpaUVQd3RqWm9fanpPWnd2S1lF?oc=5" target="_blank">European Commission’s Approval of CinnaGen’s Teriparatide Signals New Phase of Global Growth</a>  <font color="#6f6f6f">The National Law Review</font>

Read Full StoryMore like this
The European Commission’s Data-Backed Approach to International Policy
TeleGeographyworld

The European Commission’s Data-Backed Approach to International Policy

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNcmVPWXE3NURrdWZ3cnY0Q1JCanZucjNCRHNpTkZ0ZEpMUWY5SXJfcEJEQWdxb2JCSmNXcWIwaHRQY290TGprbUpZbWdVdGZneUNwcFJ3Nm05dUN3YjB2UEVuLTI0Y2ltSC1kNmxWWmZ1Xzdvem93aXpXUVA3cjhmWGRGZzJZenY4bGNCSWtTVUNYUkJobURPclloaG90UkZTdXc?oc=5" target="_blank">The European Commission’s Data-Backed Approach to International Policy</a>  <font color="#6f6f6f">TeleGeography</font>

Read Full StoryMore like this
Datroway approved in the EU as only TROP2-directed medicine with overall survival benefit for the 1st-line treatment of patients with metastatic TNBC who are not candidates for immunotherapy
AstraZenecaworld

Datroway approved in the EU as only TROP2-directed medicine with overall survival benefit for the 1st-line treatment of patients with metastatic TNBC who are not candidates for immunotherapy

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxORkMtVmt5U1Z1VVVZa2VhRk44Y1huQTFJZHY5bWhCRkhFMkhHS29ILTE2ek1nZjRueEhNSFVHdXRYS2VnQlMzV2V2a2dPYWFqMi1tMmowSHhzZ0pCTWdYSnowSTlfV2l3SWxHSXFFY1ZrSnJSZ0F5VkNVcGc0M2hPNXREZjVPYktHdFlMbEtzclZpSnl2aS1JRGFqUE9lNFk?oc=5" target="_blank">Datroway approved in the EU as only TROP2-directed medicine with overall survival benefit for the 1st-line treatment of patients with metastatic TNBC who are not candidates for immunotherapy</a>  <font color="#6f6f6f">AstraZeneca</font>

Read Full StoryMore like this
European grids package: Council backs modernised energy network for decarbonisation
consilium.europa.euworld

European grids package: Council backs modernised energy network for decarbonisation

<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxQZ1ltMmVmRmZtWDZHcmUxeTYzY0MwMW5uLWZrZUZ4QUdMdzhHNjF0T0NocFpOanU1UXd5R2k1aWNkR1FRV1RVQmJLTDZYaXJmcXpzOUFHM2oyOHVPSDVBRFZDWUwzeWlrZGx4eHI1dmRCdGJROHlybjhtRlF5ZjZwYzlKUGhKRkdPenRZVGwwemlKb1pFWmVzRkdPeUQzM2tlLVkwSFBETUpVbUNrMldfV0FyREJ5Rll2VDQwc0xsNHdBUUQwVXp0dTlXMHU3LTByY3RjMDV2bkJaV3NyTGE1ODNZRl8?oc=5" target="_blank">European grids package: Council backs modernised energy network for decarbonisation</a>  <font color="#6f6f6f">consilium.europa.eu</font>

Read Full StoryMore like this
Enanta Pharmaceuticals’ Partner AbbVie Receives European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus
Yahoo Financeworld

Enanta Pharmaceuticals’ Partner AbbVie Receives European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxNcDNXYWZuWURMRlMzdE9UUk80ankweWhZSUVzZks2UF9veHdNY1dnaTVFMDBHLW1keXphLWJnUFhuM09vS0tRXzlTSS1uUUJERjg5OWNLMnRqbDRsZ2UzOGJfWEV5ZjZKQjhUN3RjeHlXYXRBR2NJczNfUGhvSnVCVkVra1ZUZVUwUzlnQ1AyYVYtSmoxRm9iNlFHbGQtNm9naEo4a2czeDM1VlE?oc=5" target="_blank">Enanta Pharmaceuticals’ Partner AbbVie Receives European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
The EU versus Big Tech, and sanctions package approval
Euronews.comtech

The EU versus Big Tech, and sanctions package approval

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxPcmlxRFdlNEVFSFpRREE3N1ZDTVl4VmN1UU5IOUozdVRJM3NqNXdzSlg2ZHJkem9sQTNCZ1l3T2J5VE02Nk1YNFlJR1NSVFBwNkpMTkNMaWNNMFpXYjBmanZQdVVXbXlTazY0c2I0cmhNcDZWN0FhUDhQZnZnUVE1UkN4NlN3cDhDYUNsREsweHhXT1k?oc=5" target="_blank">The EU versus Big Tech, and sanctions package approval</a>  <font color="#6f6f6f">Euronews.com</font>

Read Full StoryMore like this
"European Commission appro" — Live Google News Trends & Headlines